
Clinical and pharmacogenetic determinants for the discontinuation of non-ergoline dopamine agonists in Parkinson’s disease
Maurits E. L. Arbouw, Kris L. L. Movig, Toine C. G. Egberts, Petra J. E. Poels, Jeroen P. P. van Vugt, Judith A. M. Wessels, R. J. H. M. van der Straaten, Cees Neef, Henk-Jan GuchelaarVolume:
65
Langue:
english
Pages:
7
DOI:
10.1007/s00228-009-0708-6
Date:
December, 2009
Fichier:
PDF, 117 KB
english, 2009